Nuclear receptor LRH-1/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution
Jennifer L Mamrosh,
Jae Man Lee,
Martin Wagner,
Peter J Stambrook,
Richard J Whitby,
Richard N Sifers,
San-Pin Wu,
Ming-Jer Tsai,
Francesco J DeMayo,
David D Moore
Affiliations
Jennifer L Mamrosh
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Jae Man Lee
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Martin Wagner
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Peter J Stambrook
Department of Molecular Genetics, Biochemistry, and Molecular Biology, University of Cincinnati, Cincinnati, United States
Richard J Whitby
Department of Chemistry, University of Southampton, Southampton, United Kingdom
Richard N Sifers
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States; Department of Pathology and Immunology, Baylor College of Medicine, Houston, United States
San-Pin Wu
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Ming-Jer Tsai
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Francesco J DeMayo
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
David D Moore
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States
Chronic endoplasmic reticulum (ER) stress results in toxicity that contributes to multiple human disorders. We report a stress resolution pathway initiated by the nuclear receptor LRH-1 that is independent of known unfolded protein response (UPR) pathways. Like mice lacking primary UPR components, hepatic Lrh-1-null mice cannot resolve ER stress, despite a functional UPR. In response to ER stress, LRH-1 induces expression of the kinase Plk3, which phosphorylates and activates the transcription factor ATF2. Plk3-null mice also cannot resolve ER stress, and restoring Plk3 expression in Lrh-1-null cells rescues ER stress resolution. Reduced or heightened ATF2 activity also sensitizes or desensitizes cells to ER stress, respectively. LRH-1 agonist treatment increases ER stress resistance and decreases cell death. We conclude that LRH-1 initiates a novel pathway of ER stress resolution that is independent of the UPR, yet equivalently required. Targeting LRH-1 may be beneficial in human disorders associated with chronic ER stress.